NPIPB7
gene geneOn this page
Also known as LOC440350
Summary
NPIPB7 (nuclear pore complex interacting protein family member B7, HGNC:33832) is a protein-coding gene on chromosome 16p12.1, encoding Nuclear pore complex-interacting protein family member B7 (O75200).
Predicted to be located in extracellular region.
Source: NCBI Gene 440350 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_001396030
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33832 |
| Approved symbol | NPIPB7 |
| Name | nuclear pore complex interacting protein family member B7 |
| Location | 16p12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC440350 |
| Ensembl gene | ENSG00000233232 |
| Ensembl biotype | protein_coding |
| Entrez | 440350 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000435324, ENST00000452313, ENST00000652214, ENST00000918541
RefSeq mRNA: 1 — MANE Select: NM_001396030
NM_001396030
CCDS: CCDS92130
Canonical transcript exons
ENST00000452313 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001603851 | 28462982 | 28463081 |
| ENSE00001687749 | 28462674 | 28462869 |
| ENSE00001698437 | 28466720 | 28466902 |
| ENSE00001786474 | 28458531 | 28458591 |
| ENSE00001804430 | 28458386 | 28458421 |
| ENSE00003978347 | 28470373 | 28472336 |
| ENSE00003978348 | 28456329 | 28457026 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 93.14.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 93.14 | gold quality |
| right testis | UBERON:0004534 | 92.92 | gold quality |
| testis | UBERON:0000473 | 92.39 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.33 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.88 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 81.26 | gold quality |
| cerebellar cortex | UBERON:0002129 | 81.24 | gold quality |
| cerebellum | UBERON:0002037 | 81.21 | gold quality |
| monocyte | CL:0000576 | 75.01 | gold quality |
| left ovary | UBERON:0002119 | 74.38 | gold quality |
| right ovary | UBERON:0002118 | 73.98 | gold quality |
| ovary | UBERON:0000992 | 73.80 | gold quality |
| colonic epithelium | UBERON:0000397 | 73.77 | gold quality |
| right uterine tube | UBERON:0001302 | 73.38 | gold quality |
| leukocyte | CL:0000738 | 73.26 | gold quality |
| skin of leg | UBERON:0001511 | 72.97 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 72.91 | gold quality |
| granulocyte | CL:0000094 | 72.89 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 72.42 | gold quality |
| right frontal lobe | UBERON:0002810 | 72.31 | gold quality |
| apex of heart | UBERON:0002098 | 72.29 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 72.18 | gold quality |
| primary visual cortex | UBERON:0002436 | 72.03 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 72.02 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 72.01 | gold quality |
| lower esophagus | UBERON:0013473 | 71.97 | gold quality |
| zone of skin | UBERON:0000014 | 71.81 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 71.66 | gold quality |
| transverse colon | UBERON:0001157 | 71.48 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.44 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.86 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (19): NPIPB12 (ENSG00000169203), NPIPB3 (ENSG00000169246), NPIPA1 (ENSG00000183426), NPIPA5 (ENSG00000183793), NPIPA6 (ENSG00000183889), NPIPB4 (ENSG00000185864), NPIPB15 (ENSG00000196436), NPIPB9 (ENSG00000196993), NPIPB13 (ENSG00000198064), NPIPB6 (ENSG00000198156), NPIPA8 (ENSG00000214940), NPIPA7 (ENSG00000214967), NPIPA3 (ENSG00000224712), NPIPA9 (ENSG00000233024), NPIPB2 (ENSG00000234719), NPIPB5 (ENSG00000243716), NPIPB11 (ENSG00000254206), NPIPA2 (ENSG00000254852), NPIPB8 (ENSG00000255524)
Protein
Protein identifiers
Nuclear pore complex-interacting protein family member B7 — O75200 (reviewed: O75200)
Alternative names: Nuclear pore complex-interacting protein-like 1
All UniProt accessions (3): A0A494C1T1, I3L0I5, O75200
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Similarity. Belongs to the NPIP family.
RefSeq proteins (1): NP_001382959* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009443 | NPIP | Family |
| IPR054697 | NPIP_N | Domain |
Pfam: PF06409
UniProt features (8 total): compositionally biased region 3, region of interest 2, signal peptide 1, chain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75200-F1 | 53.46 | 0.01 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 111
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 2 (showing top):
chr16p12, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0B4J1W7, A0A7H0DN35, A4QN01, A6NHN6, A6NJ64, A8MQ11, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F5HGC2, F8W1W9, F8WFD2, O75200, O83374, P05913, P06486, P07396, P0C7Q2, P0CK47, P0CK48, P0DM63, P0DXC3, P15489, P16765, P16802, P20969, P36443, P38900, P47003, P68341, P68454, P68455, P87191, P92537, P92561, Q03418, Q32M92, Q4ZGE2
Diamond homologs: A0A0B4J1W7, A6NHN6, A6NJ64, A6NJU9, A8MRT5, C9JG80, E5RHQ5, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F8W0I5, F8W1W9, F8WFD2, O75200, P0DM63, P0DXC3, Q92617, Q9UND3, O70490, Q08AH1, Q08AH3, Q3UNX5, Q53FZ2, Q5REV5, Q68CK6, Q6AYT9, Q6NUN0, Q6SKG1, Q8BGA8, Q8K0L3, Q91VA0, Q9BEA2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
792 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:28458529:A:AC | donor_gain | 1.0000 |
| 16:28458530:C:CC | donor_gain | 1.0000 |
| 16:28462672:A:AC | donor_gain | 1.0000 |
| 16:28462673:C:CC | donor_gain | 1.0000 |
| 16:28462976:CCATA:C | donor_loss | 1.0000 |
| 16:28462977:CATAC:C | donor_loss | 1.0000 |
| 16:28462978:ATACC:A | donor_loss | 1.0000 |
| 16:28462979:TA:T | donor_loss | 1.0000 |
| 16:28462980:A:AT | donor_loss | 1.0000 |
| 16:28462981:CCTTT:C | donor_gain | 1.0000 |
| 16:28463079:CAC:C | acceptor_gain | 1.0000 |
| 16:28463081:CCTA:C | acceptor_loss | 1.0000 |
| 16:28463082:C:CA | acceptor_loss | 1.0000 |
| 16:28466718:A:AC | donor_gain | 1.0000 |
| 16:28466719:C:CC | donor_gain | 1.0000 |
| 16:28466719:CA:C | donor_gain | 1.0000 |
| 16:28462690:T:TA | donor_gain | 0.9900 |
| 16:28462868:CCCT:C | acceptor_gain | 0.9900 |
| 16:28462869:CCT:C | acceptor_gain | 0.9900 |
| 16:28462871:T:C | acceptor_gain | 0.9900 |
| 16:28463077:GACAC:G | acceptor_gain | 0.9900 |
| 16:28463082:C:CC | acceptor_gain | 0.9900 |
| 16:28466711:TATAC:T | donor_loss | 0.9900 |
| 16:28466712:ATACT:A | donor_loss | 0.9900 |
| 16:28466713:TAC:T | donor_loss | 0.9900 |
| 16:28466714:AC:A | donor_loss | 0.9900 |
| 16:28466715:CT:C | donor_loss | 0.9900 |
| 16:28466716:T:TG | donor_loss | 0.9900 |
| 16:28466718:AC:A | donor_loss | 0.9900 |
| 16:28466719:CACA:C | donor_gain | 0.9900 |
AlphaMissense
2698 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:28458582:A:C | F185L | 0.966 |
| 16:28458582:A:T | F185L | 0.966 |
| 16:28458584:A:G | F185L | 0.966 |
| 16:28462823:A:C | F132L | 0.952 |
| 16:28462823:A:T | F132L | 0.952 |
| 16:28462825:A:G | F132L | 0.952 |
| 16:28466768:A:C | F67L | 0.950 |
| 16:28466768:A:T | F67L | 0.950 |
| 16:28466770:A:G | F67L | 0.950 |
| 16:28466858:A:C | F37L | 0.939 |
| 16:28466858:A:T | F37L | 0.939 |
| 16:28466860:A:G | F37L | 0.939 |
| 16:28470394:A:C | F15L | 0.926 |
| 16:28470394:A:T | F15L | 0.926 |
| 16:28470396:A:G | F15L | 0.926 |
| 16:28458420:A:G | I203T | 0.886 |
| 16:28463058:G:C | F91L | 0.868 |
| 16:28463058:G:T | F91L | 0.868 |
| 16:28463060:A:G | F91L | 0.868 |
| 16:28458565:A:G | L191S | 0.867 |
| 16:28456949:T:A | K240N | 0.853 |
| 16:28456949:T:G | K240N | 0.853 |
| 16:28457018:C:A | M217I | 0.847 |
| 16:28457018:C:G | M217I | 0.847 |
| 16:28457018:C:T | M217I | 0.847 |
| 16:28470424:A:C | F5L | 0.831 |
| 16:28470424:A:T | F5L | 0.831 |
| 16:28470426:A:G | F5L | 0.831 |
| 16:28458559:C:G | R193P | 0.830 |
| 16:28462841:C:A | K126N | 0.830 |
dbSNP variants (sampled 300 via entrez): RS1000117741 (16:28462274 G>T), RS1000423842 (16:28463590 G>T), RS1002088630 (16:28472784 G>A,T), RS1002177966 (16:28460726 G>A), RS1002544742 (16:28473218 C>T), RS1003552009 (16:28472174 A>G), RS1003573874 (16:28471943 T>C), RS1004016453 (16:28463694 C>G,T), RS1004198065 (16:28462194 T>C,G), RS1004311097 (16:28465030 C>T), RS1005022108 (16:28459050 A>G,T), RS1005023583 (16:28472674 C>G), RS1005324889 (16:28460617 G>A,C,T), RS1005400686 (16:28472908 A>G), RS1005569273 (16:28474321 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004131_83 | Inflammatory bowel disease | 2.000000e-12 |
| GCST004132_69 | Crohn’s disease | 3.000000e-10 |
| GCST004863_75 | Mosquito bite size | 5.000000e-09 |
| GCST009371_2 | Bipolar disorder or body mass index | 1.000000e-24 |
| GCST010002_111 | Refractive error | 3.000000e-09 |
| GCST010133_15 | Lamb consumption | 3.000000e-08 |
| GCST010577_14 | Crohn’s disease | 2.000000e-06 |
| GCST010703_152 | Brain morphology (MOSTest) | 3.000000e-09 |
| GCST012020_147 | Serum metabolite levels | 2.000000e-51 |
| GCST012020_152 | Serum metabolite levels | 1.000000e-45 |
| GCST012020_153 | Serum metabolite levels | 9.000000e-73 |
| GCST012021_77 | Serum metabolite levels | 1.000000e-45 |
| GCST012021_78 | Serum metabolite levels | 9.000000e-73 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008378 | mosquito bite reaction size measurement |
| EFO:0004340 | body mass index |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol F | affects cotreatment, decreases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| bisphenol S | affects cotreatment, decreases expression | 1 |
| Dexamethasone | decreases expression, affects cotreatment | 1 |
| Estradiol | affects expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Indomethacin | decreases expression, affects cotreatment | 1 |
| 1-Methyl-3-isobutylxanthine | decreases expression, affects cotreatment | 1 |
| S-Nitrosoglutathione | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.